Alan Wake 2 Quietly Crosses 3 Million Sales as Remedy Banks on Control Resonant and the Max Payne 1&2 Remakes

Remedy Entertainment dropped its half-year financial report for January through June 2026, and the headline number is a quiet one: Alan Wake 2 has now moved more than 3 million copies lifetime. That is the same Alan Wake 2 that limped out of the gate in October 2023 to a million sales, the same one that took most of two years to recoup its development and marketing budget, the same Epic Games Publishing-funded horror sequel that remains an Epic Games Store exclusive on PC and has never once appeared on Steam. Three million is not a blockbuster number by modern AAA standards, but for a 30-plus-hour, single-player, narrative-led, mid-budget thriller in an industry chasing live-service dopamine, it is a real milestone, and it confirms what the studio's own CEO said earlier this year: Alan Wake and Control should have sold more than they did. The fact that they finally have, even at this slower pace, is the only thing that matters right now.

A 3-million sales arc that took almost three years

Context matters. Alan Wake 2 launched on October 27, 2023, and was immediately crowned the fastest-selling Remedy game ever while still managing to look like a slow burn against the competition. By early 2024 the studio had only confirmed about 1 million copies sold, and the actual development and marketing cost had not yet been recouped. Roughly a year later, in February 2025, Remedy announced the sequel had crossed 2 million lifetime copies and finally started turning a profit on the project, partly thanks to sustained tail sales of the original Alan Wake Remastered. Now, a full 32 months after launch, the third million is in. That is the slowest path to 3 million for any major Remedy release in the modern era, and it tells a clear story about how a serious, story-first single-player game actually performs in a market obsessed with concurrent players and battle passes.

It also vindicates Epic's bet. Epic Games Publishing fronted the development budget and locked the PC version of Alan Wake 2 to the Epic Games Store as part of the deal, which is why Steam users who have been searching for an Alan Wake 2 page for nearly three years still get nothing. Critics and players have spent years arguing that the Epic exclusivity crushed the game's sales ceiling. They may be right on the ceiling. The 3-million number still came in, and Remedy is no longer talking about a money-losing sequel, which means the deal terms were at least tolerable for the studio. That is the part of the story that does not get retold enough: exclusivity can hurt a game's reach and still leave its publisher whole if the floor was negotiated correctly.

The financial report is mostly bad news, and that is the plan

Behind the Alan Wake 2 headline, Remedy's H1 2026 numbers look the way you would expect for a studio in heavy development and marketing mode. Revenue, operating profit, and cash flow all fell year over year, and the company is blunt about the cause: it is a period of spending on Control Resonant's final stretch, plus continued funding for the Max Payne 1 and 2 remakes and a third, still-unannounced project that has now reached production readiness. Translation: this is the expensive hole the studio deliberately dug so the rest of the decade has a pipeline coming out of it. The financial decline here is not a sign of weakness, it is the bill for a multi-year bet on four simultaneous productions.

Control Resonant is the obvious near-term focus. The stylized action game ships September 24 on PC, PS5, and Xbox Series X and S, with preorders showing what Remedy calls encouraging early momentum. Wishlists are north of 1.5 million across platforms as of August 11, and preorders have begun. As a knock-on effect, sales of the original Control actually rose year over year in Q2, beating the studio's own record for that period, which is the kind of cross-titIe lift a connected universe is supposed to deliver. The Max Payne 1 and 2 remakes, meanwhile, remain in full production at Rockstar's publishing side, and the third unannounced project has cleared the planning phase. Three live projects, one in launch mode, two in heavier crunch, and a fourth still hidden. That is the portfolio Remedy is now paying for, and the Alan Wake 2 milestone is what makes the spending possible.

Community reaction: real relief, real caveats

Reaction on Twitter and in the replies under outlets that covered the news is split between relief and a healthy dose of frustration. The relief side points to a single-player, narrative-led, mid-budget release finally reaching the kind of commercial scale its review scores always suggested it deserved. The frustration side points at the Epic Games Store exclusivity on PC and keeps asking the same question they have been asking since 2023: how many more copies would Alan Wake 2 have sold on Steam by now, and how much further along would Control Resonant's marketing budget be if the studio had the extra reach. Nobody is pretending the 3-million number is a disappointment, but plenty of people are pointing at it as a missed ceiling rather than a triumph.

What is not in question is the studio's identity. Remedy is now publicly committed to keeping Alan Wake and Control at the center of its long-term strategy, with self-publishing ambitions on its own future IP. The new CEO's earlier comments, that the studio has not achieved half of the potential of its products, reads less like a complaint now and more like a roadmap. The hardware of the connected universe is being built out: two flagship franchises, two remakes, one big sequel, and a fourth project nobody has named yet. That is a lot of weight for a studio of Remedy's size, and the Alan Wake 2 milestone is the floor under all of it.

The CriticalPixel take

Three million copies in 32 months for a single-player, mid-budget, story-first horror sequel is a win, and pretending otherwise is just industry cope. It is also not a home run, and pretending otherwise would be a disservice to a studio that has now been clear, in two consecutive financial cycles, that it knows it left money on the table. The right read is the boring one: Alan Wake 2 worked, Control Resonant has the wind at its back, and Remedy is in the messy, expensive middle of turning a good single-studio track record into a real multi-project operation. If you care about the kind of games Remedy makes, that is precisely the report you want to read. If you also happen to wish you could buy the thing on Steam, you are going to be waiting a while longer.